Hepatitis secondary to pyrazinamide toxicity: accompaniments of transient hypolipoproteinemia, acanthocytosis, and changes in stomach and small bowel.
D000012:Abetalipoproteinemia / Q000139:chemically induced*; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications*; D004913:Erythrocytes, Abnormal; D005260:Female; D005753:Gastric Mucosa / Q000000981:diagnostic imaging*; D006801:Humans; D007019:Hypoproteinemia / Q000139:chemically induced*; D007413:Intestinal Mucosa / Q000000981:diagnostic imaging*; D014176:Protein Biosynthesis; D011718:Pyrazinamide / Q000009:adverse effects*; D011859:Radiography; D013997:Time Factors
D011718:Pyrazinamide